← Every applicant
Abbott Diabetes Care, Inc. FDA Approvals
0 new drug approvals and 9 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System510(k)Apr 23, 2024Clinical Chemistry |
| FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System510(k)Apr 13, 2023Clinical Chemistry |
| FreeStyle Libre 2 Flash Glucose Monitoring System; Freestyle Libre 3 Continuous Glucose Monitoring System510(k)Mar 3, 2023Clinical Chemistry |
| FreeStyle Libre 2 System, FreeStyle Libre 3 System510(k)Feb 21, 2023Clinical Chemistry |
| FreeStyle Libre 3 Continuous Glucose Monitoring System510(k)May 26, 2022Clinical Chemistry |
| FreeStyle Libre 3 Continuous Glucose Monitoring System510(k)May 26, 2022Clinical Chemistry |
| FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)510(k)Nov 22, 2021Clinical Chemistry |
| FreeStyle Libre 2 Flash Glucose Monitoring System510(k)Aug 11, 2021Clinical Chemistry |
| FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)510(k)Jul 30, 2021Clinical Chemistry |